Sevrin; Mireille

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sevrin; Mireille.The latest application filed is for "derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic use thereof".

Company Profile

0.13.9

Sevrin; Mireille - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
DERIVATIVES OF 6-CYCLOAMINO-2-THIENYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND 6-CYCLOAMINO-2-FURANYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, PREPARATION AND THERAPEUTIC USE THEREOF App 20130190314 - Chiang; Yulin ; et al.	2013-07-25
2H or 3H-benzo[E]indazol-1-YL carbamate derivatives, the preparation and therapeutic use thereof Grant 8,258,168 - Dubois , et al. September 4, 2	2012-09-04
2h Or 3h-benzo[e]indazol-1-yl Carbamate Derivatives, The Preparation And Therapeutic Use Thereof App 20120108584 - DUBOIS; Laurent ; et al.	2012-05-03
2H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof Grant 8,114,899 - DuBois , et al. February 14, 2	2012-02-14
N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy Grant 7,951,821 - Dargazanli , et al. May 31, 2	2011-05-31
2h- Or 3h-benzo[e]indazol-1-yl Carbamate Derivatives, The Preparation And Therapeutic Use Thereof App 20090143380 - DUBOIS; Laurent ; et al.	2009-06-04
2H -or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof Grant 7,501,449 - DuBois , et al. March 10, 2	2009-03-10
N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy Grant 7,326,722 - Dargazanli , et al. February 5, 2	2008-02-05
Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy App 20070197601 - DARGAZANLI; Gihad ; et al.	2007-08-23
N-[phenyl(piperidin-2-yl)methyl]benzamide Derivatives, Preparation Thereof, And Use Thereof In Therapy App 20070155789 - DARGAZANLI; Gihad ; et al.	2007-07-05
2H-or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof App 20070105932 - DUBOIS; Laurent ; et al.	2007-05-10
N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy Grant 7,205,319 - Dargazanli , et al. April 17, 2	2007-04-17
Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics App 20050159450 - Dargazanli, Gihad ; et al.	2005-07-21
N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy App 20050153963 - Dargazanli, Gihad ; et al.	2005-07-14
4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use Grant 6,451,795 - Marguet , et al. September 17, 2	2002-09-17
1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics Grant 6,075,021 - Evanno , et al. June 13, 2	2000-06-13
5-Naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof Grant 5,922,739 - Dargazanli , et al. July 13, 1	1999-07-13
9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application Grant 5,466,706 - George , et al. November 14, 1	1995-11-14
4H-thieno[3,4-c]pyrrole derivatives Grant 5,380,742 - Sevrin , et al. January 10, 1	1995-01-10
2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole derivatives, and their application in treating depressive state, anxiety state or hypertension Grant 4,977,159 - Sevrin , et al. December 11, 1	1990-12-11
Imidazoline derivatives as .alpha..sub.2 -antagonists Grant 4,567,177 - Bigg , et al. January 28, 1	1986-01-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.